Vas Narasimhan, Novartis CEO (Simon Dawson/Bloomberg via Getty Images)

Now reimag­in­ing home, of­fice sched­ules: No­var­tis CEO Vas Narasimhan sees a new nor­mal in the post-Covid era

It’s not just small biotechs that are look­ing to com­plete­ly reeval­u­ate their need for of­fice space in a post-Covid world. It turns out No­var­tis CEO Vas Narasimhan is al­so reimag­in­ing the Big Phar­ma foot­print in the com­mer­cial re­al es­tate world.

“We’ve all learned from the pan­dem­ic that we can work from home and work from the of­fice, and it will al­ways be a com­bi­na­tion go­ing for­ward,” Narasimhan told Bloomberg Tele­vi­sion in an in­ter­view.

Endpoints Premium

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.